Edition:
United States

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349.HK)

1349.HK on Hong Kong Stock

4.16HKD
20 Oct 2017
Change (% chg)

HK$0.04 (+0.97%)
Prev Close
HK$4.12
Open
HK$4.17
Day's High
HK$4.18
Day's Low
HK$4.14
Volume
239,000
Avg. Vol
844,272
52-wk High
HK$7.41
52-wk Low
HK$3.85

Latest Key Developments (Source: Significant Developments)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical says HY revenue rmb272 million
Friday, 4 Aug 2017 06:40am EDT 

Aug 4 (Reuters) - Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd <1349.HK>::HY revenue rmb272 million versus rmb241.9 million.HY profit attributable to shareholders of company of approximately rmb49.6 million versus about rmb45.9 million​.  Full Article

Shanghai Fudan-zhangjiang Bio-pharmaceutical Co clarifies on negative rumors about co
Tuesday, 20 Jun 2017 07:18am EDT 

June 20 (Reuters) - Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd <1349.HK>:Received enquiries from investors and noticed negative rumors focusing on forecast of interim results of co.Confirmed rumors released without any prior verification or authorization & not reflects actual situation.Co has not published any information in relation to interim results of co for six months ended 30 june 2017.  Full Article

Shanghai Fudan-Zhangjiang Bio-pharma unit obtained drug approval
Monday, 17 Oct 2016 06:25am EDT 

Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd <1349.HK>:Shanghai fudan-zhangjiang bio-pharmaceutical - unit as obtained drug approval issued by china fda for hemoporfin for injection.  Full Article